日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors

性别与接受免疫检查点抑制剂治疗的微卫星不稳定性高和BRAF V600E突变转移性结直肠癌患者的预后

Nasca, Vincenzo; Zhao, Joseph; Ros, Javier; Lonardi, Sara; Zwart, Koen; Cohen, Romain; Fakih, Marwan; Jayachandran, Priya; Roodhart, Jeanine M L; Derksen, Jeroen; Intini, Rossana; Bergamo, Francesca; Mazzoli, Giacomo; Ghelardi, Filippo; Ligero, Marta; Jonnagaddala, Jitendra; Hawkins, Nicholas; Ward, Robyn L; Wankhede, Durgesh; Brenner, Hermann; Hoffmeister, Michael; Vitellaro, Marco; Salvatore, Lisa; Gallois, Claire; Laurent-Puig, Pierre; Cremolini, Chiara; Overman, Michael J; Taieb, Julien; Tougeron, David; Andre, Thierry; Kather, Jakob Nikolas; Sundar, Raghav; Carmona, Javier; Elez, Elena; Koopman, Miriam; Pietrantonio, Filippo

Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study.

肌少症、GDF-15 与 nivolumab 加 ipilimumab 治疗错配修复缺陷型转移性结直肠癌患者的疗效之间的相互作用:II 期 GERCOR NIPICOL 研究的最终生存分析

Depotte Leonard, Nay Paula, Borg Christophe, Meurisse Aurélia, Henriques Julie, Bennouna Jaafar, De La Fouchardière Christelle, Tougeron David, Mazard Thibault, Chibaudel Benoist, Tournigand Christophe, Vernerey Dewi, Pigneur Frédéric, Andre Thierry, Cohen Romain

Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer

拉罗替尼治疗TRK融合基因阳性胃肠道癌症患者的疗效和安全性

Qi, Changsong; Shen, Lin; Andre, Thierry; Chung, Hyun Cheol; Cannon, Timothy L; Garralda, Elena; Italiano, Antoine; Rieke, Damian T; Liu, Tianshu; Burcoveanu, Domnita-Ileana; Neu, Natascha; Mussi, Chiara E; Xu, Rui-Hua; Hong, David S; Drilon, Alexander; Berlin, Jordan

Associations between early tumor shrinkage/depth of response and survival from the ARCAD database

ARCAD数据库中早期肿瘤缩小/反应深度与生存率之间的关联

Bando, Hideaki; Takeda, Yuriko; Misumi, Toshihiro; Nishikawa, Tomomi; Wakabayashi, Masashi; Yamazaki, Kentaro; Oki, Eiji; Douillard, Jean-Yves; Punt, Cornelis J A; Koopman, Miriam; Van Cutsem, Eric; Bokemeyer, Carsten; Venook, Alan P; Lenz, Heinz-Josef; Maehara, Yoshihiko; Andre, Thierry; Shi, Qian; de Gramont, Aimery; Yoshino, Takayuki

MOUNTAINEER-03 phase III study design: first-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer

MOUNTAINEER-03 III期研究设计:一线mFOLFOX6+图卡替尼+曲妥珠单抗治疗HER2阳性转移性结直肠癌

Strickler, John H; Bekaii-Saab, Tanios; Cercek, Andrea; Heinemann, Volker; Nakamura, Yoshiaki; Raghav, Kanwal; Siena, Salvatore; Tabernero, Josep; Van Cutsem, Eric; Yoshino, Takayuki; Ramos, Jorge; Guan, Xuesong; Andre, Thierry

Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer

帕博利珠单抗治疗亚洲微卫星不稳定性高/错配修复缺陷型结直肠癌患者

Yoshino, Takayuki; Andre, Thierry; Kim, Tae Won; Yong, Wei Peng; Shiu, Kai-Keen; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis J A; Smith, Denis; Garcia-Carbonero, Rocio; Alcaide-Garcia, Julia; Gibbs, Peter; de la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Le, Dung T; Adachi, Noriaki; Fogelman, David; Marinello, Patricia; Diaz, Luis A Jr

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

帕博利珠单抗对比化疗治疗微卫星不稳定性高或错配修复缺陷型转移性结直肠癌(KEYNOTE-177):一项随机、开放标签、3期研究的最终分析

Diaz, Luis A Jr; Shiu, Kai-Keen; Kim, Tae-Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis; Smith, Denis; Garcia-Carbonero, Rocio; Benavides, Manuel; Gibbs, Peter; de la Fourchardiere, Christelle; Rivera, Fernando; Elez, Elena; Le, Dung T; Yoshino, Takayuki; Zhong, Wen Yan; Fogelman, David; Marinello, Patricia; Andre, Thierry

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

dMMR/MSI-H转移性结直肠癌和胃癌中的腹水和免疫检查点抑制剂耐药性

Fucà, Giovanni; Cohen, Romain; Lonardi, Sara; Shitara, Kohei; Elez, Maria Elena; Fakih, Marwan; Chao, Joseph; Klempner, Samuel J; Emmett, Matthew; Jayachandran, Priya; Bergamo, Francesca; García, Marc Díez; Mazzoli, Giacomo; Provenzano, Leonardo; Colle, Raphael; Svrcek, Magali; Ambrosini, Margherita; Randon, Giovanni; Shah, Aakash Tushar; Salati, Massimiliano; Fenocchio, Elisabetta; Salvatore, Lisa; Chida, Keigo; Kawazoe, Akihito; Conca, Veronica; Curigliano, Giuseppe; Corti, Francesca; Cremolini, Chiara; Overman, Michael; Andre, Thierry; Pietrantonio, Filippo

Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials

重新评估 III 期结肠癌辅助治疗试验中以无病生存期作为终点与以总生存期作为终点的比较

Yin, Jun; Salem, Mohamed E; Dixon, Jesse G; Jin, Zhaohui; Cohen, Romain; DeGramont, Aimery; Van Cutsem, Eric; Taieb, Julien; Alberts, Steven R; Wolmark, Norman; Schmoll, Hans-Joachim; Saltz, Leonard B; George, Thomas J; Goldberg, Richard R M; Kerr, Rachel; Lonardi, Sara; Yoshino, Takayuki; Yothers, Greg; Grothey, Axel; Andre, Thierry; Shi, Qian

Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study

瑞戈非尼及其主要代谢物M-2和M-5谷浓度对化疗难治性转移性结直肠癌患者总生存期的影响:一项多中心GERCOR TEXCAN II期研究的结果

Rousseau, Benoit; Boukerma, Arezki K; Henriques, Julie; Cohen, Romain; Lucidarme, Olivier; Borg, Christophe; Tournigand, Christophe; Kim, Stefano; Bachet, Jean-Baptiste; Mazard, Thibault; Louvet, Christophe; Chibaudel, Benoist; Vernerey, Dewi; Andre, Thierry; Hulin, Anne